INC Research Appoints Christopher Gaenzle as General Counsel
(Thomson Reuters ONE) -
Former Pfizer Assistant General Counsel Brings Extensive Legal Background to
Global CRO
Raleigh, N.C., April 10, 2012 - INC Research, LLC, a therapeutically focused
clinical research organization (CRO) with a Trusted Process(®) for delivering
reliable results, today announced Christopher L. Gaenzle has joined the Company
as its general counsel. Gaenzle will be part of INC Research's executive team
and will report to Chief Executive Officer James Ogle. As general counsel,
Gaenzle will be responsible for the Company's overall global legal strategy,
including contract negotiations, regulatory issues, strategic acquisitions,
customer projects and intellectual property matters. He will provide global
leadership for INC Research's legal resources, including management of the
Company's in-house legal department and outside counsel relationships.
"We are extremely pleased to have Chris join INC Research," said Chief Executive
Officer James Ogle. "Chris brings a wealth of experience and a solid
understanding of the regulatory and legal issues affecting the Company and the
pharmaceutical industry, and will be a valuable addition to our executive team."
Prior to joining INC Research, Gaenzle was assistant general counsel at Pfizer
Inc. His experience also includes serving as a partner at Hunton and Williams.
Gaenzle received his undergraduate degree from Colgate University and earned his
JD from Syracuse University. He was also a visiting student at Washington & Lee
University School of Law. Gaenzle is admitted to the bar in New York and
Virginia.
About INC Research
INC Research is a therapeutically focused clinical research organization with a
high-performance reputation for conducting global clinical development
programs of the highest integrity. Pharmaceutical and biotechnology companies
look to INC Research for a complete range of customized Phase I through Phase IV
programs in all therapeutic areas and innovative pediatric and women's health
trials. The Company's Trusted Process(®) methodology and therapeutic foresight
lead customers to more confident, better-informed drug and device development
decisions. INC Research is headquartered in Raleigh, NC. For more information,
please visit www.incresearch.com or follow us at (at)inc_research.
CONTACT:
Lori Dorer, Media, (513) 345-1685
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: INC RESEARCH, LLC via Thomson Reuters ONE
[HUG#1601252]
Unternehmensinformation / Kurzprofil:
Datum: 10.04.2012 - 16:37 Uhr
Sprache: Deutsch
News-ID 133584
Anzahl Zeichen: 3196
contact information:
Town:
Raleigh
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 183 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"INC Research Appoints Christopher Gaenzle as General Counsel"
steht unter der journalistisch-redaktionellen Verantwortung von
INC RESEARCH, LLC (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
